Results 61 to 70 of about 4,513 (219)

Comparative effectiveness of monotherapies and combination therapies for patients with hypertension: protocol for a systematic review with network meta-analyses [PDF]

, 2013
BACKGROUND: Hypertension has been cited as the most common attributable risk factor for death worldwide, and in Canada more than one of every five adults had this diagnosis in 2007.
Andrea Tricco, Brian Hutton, David Moher, Dean Fergusson, Edward Mills, Fatemeh Yazdi, Frans HH Leenen, Jennifer Tetzlaff, Justin Thielman, Kristian Thorlund, Lise Bjerre, Salmaan Kanji, Sharon Straus   +12 more
core   +1 more source

Polypharmacy and Potential Drug–Drug Interactions in Patients With Atrial Fibrillation

Journal of Clinical Pharmacy and Therapeutics, Volume 2025, Issue 1, 2025.
What is Known and Objective: The use of multiple medications, or polypharmacy, is associated with an elevated risk of potential drug–drug interactions (pDDIs), consequently heightening the probability of adverse drug reactions. Currently, there is a dearth of data regarding pDDIs in Chinese patients with atrial fibrillation (AF) within real‐world ...
Ying Bai, Jianqi Wang, Guangyao Li, Zhen Zhou, Nicholas B. Norgard   +4 more
wiley   +1 more source

Estimation of angiotensin-converting enzyme inhibitors protein binding degree using chromatographic hydrophobicity data [PDF]

Srpski Arhiv za Celokupno Lekarstvo, 2015
Introduction. Angiotensin-converting enzyme (ACE) inhibitors represent a significant group of drugs primarily used in the treatment of hypertension and congestive heart failure. Objective.
Trbojević-Stanković Jasna, Aleksić Mirjana, Odović Jadranka   +2 more
doaj   +1 more source

Study on the use of therapeutic group 'CO2' drugs (Antihypertensive) in Huelva province [PDF]

, 2003
Métodos: El presente trabajo analiza el consumo de medicamentos del Grupo Terapéu tico C02.Antihipertensivos, en Dosis Diaria Defrnida por cada 1 .000 habitant es y día (DHD) en cada uno de los siete Distritos Sanitarios en que se encuentra ...
Bravo Díaz, Luis, Díaz Mantis, Rafael, Díaz Paradela, Manuel, Marhuenda Requena, Elisa   +3 more
core  

Rediscovery of the implication of albuminuria in heart failure: emerging classic index for cardiorenal interaction

ESC Heart Failure, Volume 11, Issue 6, Page 3470-3487, December 2024.
Abstract The development of new drugs and device therapies has led to remarkable advancements in heart failure (HF) treatment in the past couple of decades. However, it becomes increasingly evident that guideline‐directed medical therapy cannot be one‐size‐fits‐all across a wide range of ejection fractions (EFs) and various aetiologies.
Kyung‐Duk Min, Yuki Matsumoto, Masanori Asakura, Masaharu Ishihara   +3 more
wiley   +1 more source

Effects of ACE-inhibitors and angiotensin receptor blockers on inflammation. [PDF]

, 2012
The role of inflammation in cardiovascular disease and in hypertensive disease above all, is complex. Several studies confirm that activation of renin-angiotensin-aldosterone system (RAAS), through increase in the production of angiotensin II (Ang II ...
Buttà C, DI RAIMONDO, Domenico, LICATA, Giuseppe, Miceli S, PINTO, Antonio, TUTTOLOMONDO, Antonino   +5 more
core   +1 more source

Reductions in renin‐angiotensin system inhibitors following hospitalization for heart failure

ESC Heart Failure, Volume 11, Issue 6, Page 3862-3871, December 2024.
Abstract Aims Limited data are available that evaluate the efficacy of renin‐angiotensin system inhibitor (RASI) dose‐reduction in older adults with heart failure with reduced ejection fraction following a heart failure hospitalization. Methods and results We examined a 5% random sample of Medicare beneficiaries with prescription coverage who were ...
Parag Goyal, Ligong Chen, Jennifer D. Lau, Robert S. Rosenson, Emily B. Levitan   +4 more
wiley   +1 more source

Pilot trial of an electronic decision support to improve care for emergency department patients with acute heart failure

ESC Heart Failure, Volume 11, Issue 6, Page 4432-4436, December 2024.
Abstract Aims Emergency department (ED) providers play an important role in the management of patients with acute heart failure (AHF). We present findings from a pilot study of an electronic decision support that includes personalized risk estimates using the STRIDE‐HF risk tool and tailored recommendations for initiating guideline directed medical ...
Dana R. Sax, Dustin G. Mark, Jamal S. Rana, Jie Huang, Scott D. Casey, Robert P. Norris, Viliami Tillage, Mary E. Reed   +7 more
wiley   +1 more source

Influence of asilsartan medoxomile on arterial hypertension variability in patients with arterial hypertension and chronic obstructive pulmonary disease

Лечащий Врач, 2021
We studied hypotensive effects, as well as short-term, daily and long-term variability of arterial pressure against the background of treatment with angiotensin-transforming ferment inhibitor and angiotensin-ferment blockers II in patients with arterial ...
N. Yu. Grigorieva, M. E. Koroleva
doaj  

Possibilities of using Fosinopril, an angiotensinconverting enzyme inhibitor, combined with Diltiazem, a non-dihydropyridine calcium antagonist, as first-line therapy in the treatment of arterial hypertension (clinical case)

Медицинский совет, 2019
The article exemplified the successful experience of using combination therapy consisting of fosinopril, an angiotensin-converting enzyme inhibitor, and diltiazem, a non-dihydropyridine calcium antagonist, in a patient with a history of arterial ...
O. D. Ostroumova, I. V. Goloborodova
doaj   +1 more source